Pessaries

03/01/2001 - "The cube and Gellhorn pessaries were thought to be the most effective for vaginal vault prolapse. "
06/01/2011 - "Although there is evidence that the use of pessaries in the treatment of pelvic organ prolapse is effective in alleviating symptoms and that patient satisfaction is high, the follow-up in many published papers is short, and the use of validated urogynaecological questionnaires is limited. "
01/01/2011 - "Use of a pessary in treatment of pelvic organ prolapse is associated with good compliance, and results in significant improvement in quality of life and urinary and bowel symptoms. "
07/01/2000 - "Neonatal pelvic organ prolapse has also been treated successfully with pessaries. "
10/01/2011 - "Vaginal pessaries are safe, simple and effective treatment for pelvic organ prolapse. "

06/01/2011 - "Most studies report moderate success rates in the short term following insertion of a pessary for the management of prolapse and concur in the remission of almost all symptoms attributable to the prolapse. "
05/01/2011 - "This analysis indicates that pessary use and VRS are the most cost-effective treatment alternatives for treating post-hysterectomy vaginal prolapse. "
12/01/2007 - "Pessaries effectively treated urinary symptoms, and most effectively treated prolapse symptoms. "
03/01/2011 - "There was a statistically significant improvement in prolapse, urinary, bowel, and sexual function in both pessary users and those treated surgically. "
05/01/2006 - "After controlling for preoperative prolapse stage and baseline quality of life scores, subjects in the Surgery group had significantly greater improvement in each of the scales of the PFDI and the prolapse and urinary scales of the PFIQ than did the Pessary group (P < .05 for each). "

02/01/2003 - "Clinical studies of ultra-low dose rings have shown them to be as efficacious as established treatments of urogenital atrophy (creams, pessaries) and to be preferred by most users. "
04/01/2012 - "The aim of the study was to confirm the superior efficacy of estriol containing pessaries compared to placebo in the treatment of vaginal atrophy. "
04/01/2012 - "Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol."
04/01/2012 - "Superiority of estriol containing pessaries over placebo was shown in the local treatment of vaginal atrophy. "
04/01/2012 - "In a prospective, multicenter, randomized, placebo-controlled, double-blind study, 436 postmenopausal women with vaginal atrophy (vaginal maturation index, VMI<40%; vaginal pH>5; most bothersome symptom, MBS≥65 on visual analogue scale, VAS) were treated with pessaries containing either 0.2mg estriol (N=142) or 0.03mg estriol (N=147) or with a matching placebo (N=147) for 12 weeks. "

09/01/2008 - "Ninety-two women with vaginitis participated in this phase 3 study using one vaginal pessary daily for 7 days. "
07/01/2001 - "Chemical vaginitis resulting from insertion of caustic vaginal pessaries for various reasons was the major cause of acquired gynaetresia. "
01/01/1996 - "Neo-Penotran pessaries represent a novel and effective formulation for the treatment of common types of vaginitis and this pessary may also be of particular value in the treatment of resistant or recurrent vaginitis."
01/01/1993 - "In a general-practice clinical trial of the treatment of vaginitis in 80 patients, Neotran pessaries achieved a microbiological resolution rate of 83% in those patients who were bacteriologically evaluable and was well tolerated. "
01/01/1993 - "A vaginal pessary has been formulated to provide an effective therapy in all three forms of vaginitis mentioned above. "

01/01/2013 - "To evaluate the efficacy of cervical pessary for the prevention of preterm birth in women with risk factors for cervical incompetence. "
01/01/2010 - "To evaluate the efficacy of cervical pessary for prevention of preterm birth in women with cervical incompetence. "
09/01/2014 - "Re: Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial). "
09/01/2014 - "Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial)."
10/19/2013 - "Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial."